Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system

Neuropharmacology

Volumn 43, Issue 1, 2002, Pages 101-109

  Keck, M E ^a   Welt, T ^a   Muller M B ^a   Erhardt, A ^a   Ohl, F ^a   Toschi, N ^a   Holsboer, F ^a   Sillaber, I ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Antidepressant; Biogenic amines; Depression; Microdialysis; Monoamines; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; HOMOVANILLIC ACID; URETHAN;

ACCURACY; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CONTROLLED STUDY; DENSITY; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIMBIC CORTEX; MALE; MICRODIALYSIS; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STRIATE CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CONSCIOUSNESS; CORPUS STRIATUM; DOPAMINE; ELECTRIC STIMULATION; ELECTROMAGNETICS; HIPPOCAMPUS; MALE; MICRODIALYSIS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR;

EID: 0036630077     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00069-2     Document Type: Article

References (64)

1. Alonso S.J., Navarro E., Rodriguez M. Permanent dopaminergic alterations in the n. accumbens after prenatal stress. Pharmacology, Biochemistry and Behavior. 49:1994;353-358.
2. Ben-Shachar D., Belmaker R.H., Grisaru N., Klein E. Transcranial magnetic stimulation induces alterations in brain monoamines. Journal of Neural Transmission. 104:1997;191-197.
3. Ben-Shachar D., Gazawi H., Riboyad-Levin J., Klein E. Chronic repetitive transcranial magnetic stimulation alters β-adrenergic and 5-HT2 receptor characteristics in rat brain. Brain Research. 816:1999;78-83.
4. Berman R.M., Narasimhan M., Sanacora G., Miano A.P., Hoffman R.E., Hu X.S., Charney D.S., Boutros N.N. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression. Biological Psychiatry. 47:2000;332-337.
5. Berridge K.C., Robinson T.E. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Research Review. 28:1998;309-369.
6. Blier P., de Montigny C. Current advances and trends in the treatment of depression. Trends in Pharmacological Science. 15:1994;220-226.
7. Borsini F., Meli A. The forced swimming test. Its contribution to the understanding of the mechanisms of action of antidepressants. Gessa G.L., Serra G., Dopamine and Mental Depression. 1990;63-76 Pergamon Press, Oxford.
8. Bowden C., Cheetham S.C., Lowther S., Katona C.L.E., Crompton M.R., Horton R.W. Reduced dopamine turnover in the basal ganglia of depressed suicides. Brain Research. 769:1997;135-140.
9. Brown A.S., Gershon S. Dopamine and depression. Journal of Neural Transmission. General Section. 91:1993;75-109.
10. Caine S.B., Heinrichs S.C., Coffin V.L., Koob G.F. Effects of the dopamine D1 antagonist SCH 23390 microinjected into the nucleus accumbens, amygdala or striatum on cocaine self-administration in the rat. Brain Research. 692:1995;47-56.
11. Carboni E., Tanda G.L., Frau R., Di Chiara G. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. Journal of Neurochemistry. 55:1990;1067-1070.
12. Carlezon W.A. Jr., Wise R.A. Rewarding actions of phencyclidine and related drugs in the nucleus accumbens shell and frontal cortex. Journal of Neuroscience. 16:1996;3112-3122.
13. Carr D.B., Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. Journal of Neuroscience. 15:2000;3864-3873.
14. Cervo L., Samanin R. Repeated treatment with imipramine and amitriptyline reduces the immobility of rats in the swimming test by enhancing dopamine mechanisms in the nucleus accumbens. Journal of Pharmacy and Pharmacology. 40:1988;155-156.
15. Cohen E., Bernardo M., Masana J., Arrufat F.J., Navarro V., Valls-Solé J., Boget T., Barrantes N., Catarineu S., Font M., Lomena F.J. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. Journal of Neurology, Neurosurgery and Psychiatry. 67:1999;129-130.
16. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides. 5:1994;731-755.
17. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. Journal of Psychopharmacology. 12:1998;54-67.
18. Feenstra M.G.P., Botterblom M.H.A., van Uum J.F.M. Local activation of metabotropic gluatamate receptors inhibits the handling-induced increased release of dopamine in the nucleus accumbens but not that of dopamine or noradrenaline in the prefrontal cortex: comparison with inhibition of ionotropic reecptors. Jounal of Neurochemistry. 70:1998;1104-1113.
19. Feldman R.S., Meyer J.S., Quenzer L.F. Principles of Neuropsychopharmacology. 1997;Sinauer, Sunderland.
20. Fibiger H.C. Neurobiology of depression: focus on dopamine. Depression and Mania. 49:1995;1-17.
21. Fleischmann A., Prolov K., Abarbanel J., Belmaker R.H. The effect of transcranial magnetic stimulation of rat brain on behavioral models of depression. Brain Research. 699:1995;130-132.
22. Fuxe K., Agnati L.F., Kalia M., Goldstein M., Andersson K., Härfstrand A. Dopaminergic systems in the brain and pituitary. Müller E.E., Thorner M.O., Basic and Clinical Aspects of Neuroscience: The Dopaminergic System. 1985;11-25 Springer Verlag, Berlin.
23. George M.S., Lisanby S., Sackeim H.A. Transcranial magnetic stimulation. Archives of General Psychiatry. 56:1999;300-311.
24. George M.S., Nahas Z., Molloy M., Speer A.M., Oliver N.C., Li X.B., Arana G.W., Risch S.C. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biological Psychiatry. 48:2000;962-970.
25. Grace A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
26. Greene E.C. Anatomy of the Rat. 1963;Hafner Publishing Company, New York and London.
27. Grisaru N., Chudakov B., Yaroslavsky Y., Belmaker R.H. Catatonia treated with transcranial magnetic stimulation. American Journal of Psychiatry. 155:1998;1630.
28. Grisaru N., Chudakov B., Yaroslavsky Y., Belmaker R.H. Transcranial magnetic stimulation in mania: a controlled study. American Journal of Psychiatry. 155:1998;1608-1610.
29. Grunhaus L., Dannon P.N., Schreiber S., Dolberg O.H., Amiaz R., Ziv R., Lefkifker E. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biological Psychiatry. 47:2000;314-324.
30. Heimer L., Harlan R.E., Alheid G.F., Garcia M.M., De Olmos J. Substantia innominata: a notion which impedes clinical-anatomical correlations in neuropsychiatric disorders. Neuroscience. 76:1997;957-1006.
31. Holsboer F. Neuroendocrinology of mood disorders. Bloom F.E., Kupfer D.J., Psychopharmacology: The Fourth Generation of Progress. 1995;957-968 Raven Press, New York.
32. Keck M.E., Engelmann M., Müller M.B., Henniger M.S.H., Hermann B., Rupprecht R., Neumann I.D., Toschi N., Landgraf R., Post A. Repetitive transcranial magnetic stimulation induces active coping strategies and attenuates the neuroendocrine stress response in rats. Journal of Psychiatric Research. 34:2000;265-276.
33. Keck M.E., Sillaber I., Ebner K., Welt T., Toschi N., Kaehler S.T., Singewald N., Philippu A., Elbel G.K., Wotjak C.T., Holsboer F., Landgraf R., Engelmann M. Acute transcranial magnetic stimulation of frontal brain regions selectively modulates the release of vasopressin, biogenic amines and amino acids in the rat brain. European Journal of Neuroscience. 12:2000;3713-3720.
34. Keck M.E., Welt T., Post A., Müller M.B., Toschi N., Wigger A., Landgraf R., Holsboer F., Engelmann M. Neuroendocrine and behavioral effects of repetitive transcranial magnetic stimulation in a psychopathological animal model are suggestive of antidepressant-like effects. Neuropsychopharmacology. 24:2001;337-349.
35. Le Moal M., Simon H. Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiological Review. 71:1991;155-234.
36. Lindvall O., Björklund A. Dopamine and norepinephrine containing neuron systems: their anatomy in the rat brain. Emson P.C., Chemical Neuroanatomy. 1983;229-255 Raven Press, New York.
37. Mally J., Stone T.W. Therapeutic and dose-dependent effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease. Journal of Neuroscience Research. 57:1999;935-940.
38. Müller M.B., Toschi N., Kresse A.E., Post A., Keck M.E. Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain. Neuropsychopharmacology. 23:2000;205-215.
39. Nahas Z., Molloy M., Risch S.C., George M.S. TMS in schizophrenia. George M.S., Belmaker R.H., Transcranial Magnetic Stimulation in Neuropsychiatry. 2000;237-252 American Psychiatric Press Inc. Washington, DC.
40. Padberg F., Zwanzger P., Thoma H., Kathmann N., Haag C., Greenberg B.D., Hampel H., Möller H.J. Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS. Psychiatry Research. 88:1999;163-171.
41. Pascual-Leone A., Rubio B., Pallardo F., Catala M.D. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet. 348:1996;233-237.
42. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Sydney, Academic Press.
43. Post A., Keck M.E. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms? Journal of Psychiatric Research. 35:2001;193-215.
44. Post A., Müller M.B., Engelmann M., Keck M.E. Repetitive transcranial magnetic stimulation in rats: evidence for a neuroprotective effect in vitro and in vivo. European Journal of Neuroscience. 11:1999;3247-3254.
45. Post R.M., Gerner R.H., Carman J.S., Gillin C., Jimerson D.C., Goodwin F.K., Bunney W.E. Effects of a dopamine agonist piribedil in depressed patients-relationship of pretreatment homovanillic acid to antidepressant response. Archives of General Psychiatry. 35:1978;609-615.
46. Rampello L., Nicoletti G., Raffaele R. Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses. Acta Psychiatrica Scandinavica. 84:1991;552-554.
47. Rollnik J.D., Huber T.J., Mogk H., Siggelkow S., Kropp S., Dengler R., Emrich H.M., Schneider U. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport. 11:2000;4013-4015.
48. Roy A., Pickar D., Linnoila M., Doran A.R., Ninan P., Paul S.M. Cerebrospinal fluid monoamine metabolite concentrations in melancholia. Psychiatry Research. 15:1985;281-292.
49. Sackeim H.A. Repetitive transcranial magnetic stimulation: what are the next steps? Biological Psychiatry. 48:2000;959-961.
50. Sesack S.R., Pickel V.M. Prefrontal cortex efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. Journal of Comparative Neurology. 320:1992;145-160.
51. Siebner H.R., Rossmeier C., Mentschel C., Peinemann A., Conrad B. Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's disease. Journal of the Neurological Science. 178:2000;91-94.
52. Sillaber I., Montkowski A., Landgraf R., Barden N., Holsboer F., Spanagel R. Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide. Neuroscience. 85:1998;415-425.
53. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. Journal of Neurochemistry. 55:1990;1734-1740.
54. Strafella A.P., Paus T., Barrett J., Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. Journal of Neuroscience. 21:(RC157):2001;1-4.
55. Swerdlow N.R., Koob G.F. Dopamine, schizophrenia, mania, and depression: toward a unified hypothesis of cortico-striato-pallido-thalamic function. Behavoral Brain Science. 10:1987;197-245.
56. Taber M.T., Fibiger H.C. Electrical stimulation of the prefrontal cortex increases dopamine release in the nucleus accumbens of the rat: modulation by metabotropic glutamate receptors. Journal of Neuroscience. 15:1995;3896-3904.
57. Taber M.T., Das S., Fibiger H.C. Cortical regulation of subcortical dopamine release: mediation via the ventral tegmental area. Journal of Neurochemistry. 65:1995;1407-1410.
58. West C.H.K., Bonsall R.W., Emery M.S., Weiss J.M. Rats selectively bred for high and low swim-test activity show differential responses to dopaminergic drugs. Psychopharmacology. 146:1999;241-251.
59. Westerink B.H.C. Brain microdialysis and its application for the study of animal behaviour. Behavoral Brain Research. 70:1995;103-124.
60. Willner P. The mesolimbic dopamine system as a target for rapid antidepressant action. International Clinical Psychopharmacology. 12:1997;7-14.
61. Yadid G., Overstreet D.H., Zangen A. Limbic dopaminergic adaptation to a stressful stimulus in a rat model of depression. Brain Research. 896:2001;43-47.
62. Yoshida K., Higuchi H., Kamata M., Yoshimoto M., Shimizu T., Hishikawa Y. Dopamine releasing response in rat striatum to single and repeated electroconvulsive shock treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 21:1997;707-715.
63. You Z.B., Tzschentke T.M., Brodin E., Wise R.A. Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats. Journal of Neuroscience. 18:1998;6492-6500.
64. Zwanzger P., Ella R., Keck M.E., Rupprecht R., Padberg F. Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression. Biological Psychiatry. 51:2002;602-603.